Exchange: NYSEMkt·Updated 01:35 AM EDT
AZTR logo

AZTR Azitra Inc

$0.1686
$0.0081
(4.58%)
Overnight
Prev Close $0.1767
Reported EarningsAug 12
Mkt Cap$10.61M
Vol373,817.00

About AZTR

Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.
60

Bullish Sentiment

How do you feel about AZTR?

Advertisement|Remove ads.